E6BP Activators
E6BP Activators encompass a diverse group of chemical compounds that enhance the functional activity of E6BP through various signaling pathways and cellular processes. Forskolin, for instance, by increasing cAMP levels, can activate PKA, which may phosphorylate E6BP, thereby enhancing its activity. The potential for PKA to target E6BP is based on the common role of PKA in phosphorylating various proteins to modulate their functions.
Similarly, PMA, through the activation of PKC, could also lead to the phosphorylation of E6BP, suggesting a role for PKC-mediated pathways in the modulation of E6BP's activity. Ionomycin, by raising intracellular calcium levels, indirectly activates calcium-dependent kinases, which could phosphorylate E6BP and enhance its activity, given the broad impact of calcium signaling in the cell.Furthermore, signaling molecules like EGF and insulin can initiate pathways that ultimately lead to the activation of kinases capable of phosphorylating E6BP.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing levels of cAMP in the cell. Elevated cAMP can enhance the PKA pathway, which could phosphorylate E6BP, enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate target proteins. PKC-mediated phosphorylation of E6BP may enhance its activity by promoting its interaction with other proteins. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation leads to the PI3K/Akt signaling pathway, which could enhance E6BP activity through phosphorylation events that affect its functional state. | ||||||
Conjugated Estrogen | 12126-59-9 | sc-357319 sc-357319A | 25 mg 100 mg | $153.00 $468.00 | ||
Estrogen binds to estrogen receptors, which can modulate various signaling pathways. Estrogen receptor activation could lead to changes in E6BP activity through downstream signaling effects. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP that activates PKA. PKA activation can enhance E6BP activity through phosphorylation at specific sites critical for its function. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, potentially leading to the activation of PKA and subsequent phosphorylation and enhancement of E6BP activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors, which can modulate gene expression. Altered gene expression could lead to changes in the cellular environment that enhance E6BP activity. | ||||||